Skip to content

Indolent B Cell Non Hodgkin Lymphoma C5419078

Published: July 22, 2026Updated: August 20, 2026

A slow-growing cancer of the lymphatic system involving B cells. Treatment may include watchful waiting or gentle therapies, with many patients having a favorable long-term outlook.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(oncologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Painless lymphadenopathy

(oncologic)

Fatigue

(oncologic)

Night sweats

(oncologic)

Mild weight loss

(oncologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Active Surveillance Strategy

Watchful waiting approach with regular monitoring of disease progression through physical exams and imaging studies, delaying active treatment until disease progression occurs.

monitoring
2

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Anti-CD20 Monoclonal Antibody Therapy

Immunotherapy using monoclonal antibodies targeting the CD20 antigen on B-cells, which has demonstrated efficacy in controlling indolent lymphoma growth with favorable tolerability.

medication

Additional treatment options

Targeted Small Molecule Inhibitors

Oral targeted therapies that inhibit specific signaling pathways in lymphoma cells, offering an alternative to chemotherapy with different side effect profiles.

medication

Localized Radiation Therapy

Focused radiation treatment for limited-stage disease or symptomatic sites, providing high response rates with limited toxicity for localized disease manifestations.

procedure

Supportive Care and Wellness Optimization

Implementation of lifestyle modifications including balanced nutrition, appropriate exercise, stress management, and infection prevention to support overall health during treatment and monitoring.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Indolent B Cell Non Hodgkin Lymphoma C5419078?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

NCCN Clinical Practice Guidelines in Oncology. B-Cell Lymphomas Version 3.2023. J Natl Compr Canc Netw. 2023.

guideline2023
2

Freilich R, Berg D, Thompson CA, Marcus R. The evolving landscape of indolent B-cell lymphoma management. Blood Adv. 2022.

review2022
3

Marcus R, Davies A, Ando K, et al. Obinutuzumab plus bendamustine followed by obinutuzumab maintenance versus bendamustine monotherapy in patients with previously untreated follicular lymphoma: results from the GADOLIN trial. J Clin Oncol. 2017.

clinical_trial2017
4

Liu Q, Shi J, Huang J, et al. Comparative efficacy and safety of first-line treatments for indolent non-Hodgkin lymphoma: a systematic review and network meta-analysis. Lancet Haematol. 2021.

meta_analysis2021

Medication Comparisons

Compare medications used to treat Indolent B Cell Non Hodgkin Lymphoma C5419078. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy